Crohn’s disease-associated IgA nephropathy may prone to better renal outcome

de Souza HS, Fiocchi C (2016) Immunopathogenesis of IBD: current state of the art. Nat Rev Gastroenterol Hepatol 13(1):13–27

Article  PubMed  Google Scholar 

Pardi DS, Tremaine WJS, McCarthy JT (1998) Renal and urologic complications of inflammatory bowel disease. Am J Gastroenterol 93(4):504–514

Article  CAS  PubMed  Google Scholar 

Ambruzs JM, Walker PD, Larsen CP (2014) The histopathologic spectrum of kidney biopsies in patients with inflammatory bowel disease. Clin J Am Soc Nephrol CJASN 9(2):265–270

Article  PubMed  Google Scholar 

Gesualdo L, Di Leo V, Coppo R (2021) The mucosal immune system and IgA nephropathy. Semin Immunopathol 43(5):657–668

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fellström BC, Barratt J, Cook H, Coppo R, Feehally J, de Fijter JW, Floege J, Hetzel G, Jardine AG, Locatelli F et al (2017) Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial. The Lancet 389(10084):2117–2127

Article  Google Scholar 

Forshaw MJ, Guirguis O, Hennigan TW (2005) IgA nephropathy in association with Crohn’s disease. Int J Colorectal Dis 20(5):463–465

Article  CAS  PubMed  Google Scholar 

Filiopoulos V, Trompouki S, Hadjiyannakos D, Paraskevakou H, Kamperoglou D, Vlassopoulos D (2010) IgA nephropathy in association with Crohn’s disease: a case report and brief review of the literature. Ren Fail 32(4):523–527

Article  PubMed  Google Scholar 

Bernstein CN, Eliakim A, Fedail S, Fried M, Gearry R, Goh K-L, Hamid S, Khan AG, Khalif I, Ng SC et al (2016) World Gastroenterology Organisation Global Guidelines Inflammatory Bowel Disease: Update August 2015. J Clin Gastroenterol 50(10):803–818

Article  PubMed  Google Scholar 

Best WR, Becktel JM, Singleton JW, Kern F Jr (1976) Development of a Crohn’s disease activity index. Natl Cooper Crohn’s Dis Study Gastroenterol 70(3):439–444

CAS  Google Scholar 

Hubert D, Beaufils M, Meyrier A (1984) Immunoglobulin A glomerular nephropathy associated with inflammatory colitis. Apropos of 2 cases. Presse medicale (Paris, France : 1983) 13(17):1083–1085

Zhao L, Ren G, Fan R, Feng X, Liu Z, Cheng Z, Zhang T (2022) Spectrum and prognosis of renal histopathological lesions in patients with inflammatory bowel disease: a cross-sectional study from a single center in China. Clin Exp Med 22(4):629–635

Article  CAS  PubMed  Google Scholar 

Cheung CK, Barratt J (2022) Further evidence for the mucosal origin of pathogenic IgA in IgA nephropathy. J Am Soc Nephrol JASN

Yuan J, Wang Z, Wang YP (2022) Identification of common key genes associated with Crohn’s Disease and IgA nephropathy. Eur Rev Med Pharmacol Sci 26(10):3607–3620

CAS  PubMed  Google Scholar 

Coppo R, Roccatello D, Amore A, Quattrocchio G, Molino A, Gianoglio B, Amoroso A, Bajardi P, Piccoli G (1990) Effects of a gluten-free diet in primary IgA nephropathy. Clin Nephrol 33(2):72–86

CAS  PubMed  Google Scholar 

Dong J, Chen Y, Tang Y, Xu F, Yu C, Li Y, Pankaj P, Dai N (2015) Body mass index is associated with inflammatory bowel disease: a systematic review and meta-analysis. PLoS One 10(12):e0144872

Article  PubMed  PubMed Central  Google Scholar 

Akiyama M, Shimomura K, Yoshimoto H, Sako M, Kodama M, Abe K, Gunji M, Kang D, Takaki T, Wada Y et al (2022) Crohn’s disease may promote inflammation in IgA nephropathy: a case-control study of patients undergoing kidney biopsy. Virchows Archiv Int J Pathol 481(4):553–563

Article  CAS  Google Scholar 

Bellur SS, Troyanov S, Vorobyeva O, Coppo R, Roberts IS (2024) Evidence from the large VALIGA cohort validates the subclassification of focal segmental glomerulosclerosis in IgA nephropathy. Kidney Int S0085–2538(24):00235–00237

Google Scholar 

Terasaka T, Uchida HA, Umebayashi R, Tsukamoto K, Tanaka K, Kitagawa M, Sugiyama H, Tanioka H, Wada J (2016) The possible involvement of intestine-derived IgA1: a case of IgA nephropathy associated with Crohn’s disease. BMC Nephrol 17(1):122

Article  PubMed  PubMed Central  Google Scholar 

Song DJ, Shen J, Chen MH, Liu ZJ, Cao Q, Hu PJ, Gao X, Qian JM, Wu KC, Lai LJ et al (2021) Association of serum immunoglobulins levels with specific disease phenotypes of Crohn’s disease: a multicenter analysis in China. Front Med 8:621337

Article  Google Scholar 

Rai T, Wu X, Shen B (2015) Frequency and risk factors of low immunoglobulin levels in patients with inflammatory bowel disease. Gastroenterol Rep 3(2):115–121

Article  Google Scholar 

Liu D, You J, Liu Y, Tang X, Tan X, Xia M, Wu L, Chen G, He L, Zhu X et al (2019) Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy. Int Immunopharmacol 66:13–18

Article  CAS  PubMed  Google Scholar 

Mole CM, Renoult E, Béné MC, Seillès E, Kessler M, Revillard JP, Faure GC (1995) Serum secretory IgA and IgM and free secretory component in IgA nephropathy. Nephron 71(1):75–78

Article  CAS  PubMed  Google Scholar 

Joher N, Gosset C, Guerrot D, Pillebout E, Hummel A, Boffa JJ, Faguer S, Rabant M, Higgins S, Moktefi A et al (2022) Immunoglobulin A nephropathy in association with inflammatory bowel diseases: results from a national study and systematic literature review. Nephrol Dial Transplant 37(3):531–539

Article  CAS  PubMed  Google Scholar 

Hassler JR (2020) IgA nephropathy: a brief review. Semin Diagn Pathol 37(3):143–147

Article  PubMed  Google Scholar 

Wyatt RJ, Julian BA (2013) IgA nephropathy. N Engl J Med 368(25):2402–2414

Article  CAS  PubMed  Google Scholar 

Zhang G, Tian Z, Xue Q (2022) Comparison of clinical and pathological features of secondary IgA nephropathy of ankylosing spondylitis and primary IgA nephropathy. Clin Nephrol 97(5):273–280

Article  CAS  PubMed  Google Scholar 

Riley AM, Wall BM, Cooke CR (2009) Favorable outcome after aggressive treatment of infection in a diabetic patient with MRSA-related IgA nephropathy. Am J Med Sci 337(3):221–223

Article  PubMed  Google Scholar 

Lee M, Suzuki H, Kato R, Fukao Y, Nakayama M, Kano T, Makita Y, Suzuki Y (2021) Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy. CEN Case Rep 10(1):17–22

Article  CAS  PubMed  Google Scholar 

Tang X, Zheng J, Jiang X, Wan F, Hou X, Liu S, Zhang M, Song Y, Ye T, Yu J (2023) The significance of galactose-deficient immunoglobulin A1 staining in kidney diseases with IgA deposition. Int Urol Nephrol 55(8):2119–2129

Article  CAS  PubMed  Google Scholar 

Cassol CA, Bott C, Nadasdy GM, Alberton V, Malvar A, Nagaraja HN, Nadasdy T, Rovin BH, Satoskar AA (2020) Immunostaining for galactose-deficient immunoglobulin A is not specific for primary immunoglobulin A nephropathy. Nephrol Dial Transplant 35(12):2123–2129

Article  CAS  PubMed  Google Scholar 

留言 (0)

沒有登入
gif